Background: Endometriosis impacts 6-10% of all reproductive-age women. Studies have shown the more effectively endometriosis is removed, the better the patient outcomes for pain reduction and fertility (2, 3). Hemosiderin, glands, and stroma are the histologic markers of endometriosis; optical coherence tomography (OCT) can identify glands and hemosiderin has a known endogenous fluorescence than can be detected by two-photon microscopy (TPM). The hypothesis was that the identification of optical properties of endometriosis using OCT and TPM combined would improve a surgeon's ability to diagnose and treat by improving endometriosis detection compared to current standards of visual diagnosis. Methods: Forty-one women with clinically suspected endometriosis undergoing laparoscopy were consented. Women were enrolled at two clinical sites: University of Texas Health Science Center, San Antonio and Methodist Healthcare System, San Antonio. The surgeon made a clinical diagnosis of suspected endometriosis as 1) yes present 2) maybe present, and 3) not present (controls) from the peritoneum without suspected disease. One-hundred-twenty biopsies were collected from 27 women with visually suspected endometriosis. All three patient biopsy classes were excised and underwent histologic examination as the gold-standard diagnosis for endometriosis. The samples were imaged ex-vivo for optical markers of endometriosis; OCT for endometrial glands and TPM for hemosiderin. Histologic markers were coregistered with optical properties. Biopsies were embedded in agar to maintain orientation during imaging and histological processing. TPM used the endogenous fluorescence of hemosiderin as a marker. OCT used glands as a marker. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were calculated. Results: The main-outcome-measure was the statistical comparison of clinical impression, imaging results, and histologic truth. Glands, stroma and hemosiderin were present in 49, 72 and 86% of endometriosis samples confirmed by histology. Clinical suspicion of endometriosis had 98% sensitivity, 53% specificity, 68% PPV, and 96% NPV. In 31 samples of endometriosis maybe being present, 39% were histologically confirmed. Eighty-eight samples were analyzed using OCT-TPM. OCT-TPM had 93% sensitivity, 100% specificity, 100% PPV, and 93% NPV. Conclusions: OCT-TPM is useful in identifying endometriosis' presence or absence. Evaluation of suspected endometriosis by OCT-TPM improves surgeons' abilities to diagnose and treat endometriosis.
Background
Endometriosis impacts 6-10% of all reproductive-age women [1] . The gold standard for diagnosis and treatment of endometriosis is laparoscopic inspection and excision or ablation with histologic confirmation. Studies have shown the more effectively endometriosis is removed, the better the patient outcomes for pain reduction and fertility [2, 3] . However, of the tissue removed during laparoscopy, less than 70% is confirmed as endometriosis on histologic diagnosis [4] . With a 30-40% recurrence rate for symptomatic endometriosis after laparoscopic surgery, due to incomplete surgical excision [5] , there are clearly short-comings in the current surgical diagnosis and management of endometriosis. During laparoscopic surgery, the surgeon's goal is identification of each endometriosis lesion and sequential excision of each implant. Complicating the time consuming process of identification and removal is the potential widespread distribution of endometriosis lesions throughout the abdominal and pelvic cavities. The distribution of these lesions presents a challenge to all surgeons whose diagnostic imaging tools are normally limited to an unaided eye and laparoscope with some endometriosis not being immediately discernible from surrounding tissue. The nature of the iceberg geometry of endometriosis lesions complicates the surgery since frequently only a fraction of the lesion is visible with the remaining endometriosis lesion located below the surface. Because the surgeon is faced with the divergent challenges of removing all endometrial lesions without damaging delicate underlying tissues and structures, prolonged surgeries are common and only partially successful. Patient outcomes suffer because no effective imaging tools are currently available in the operating room to allow endometriosis lesions to be discerned from surrounding tissues [6] .
The current study presents novel solutions for the detection of endometriosis, using optical coherence tomography and two photon microscopy (OCT-TPM) imaging. Hemosiderin is known to have specific excitation/emission wavelengths [7, 8] . We hypothesized that we could identify hemosiderin as a marker in endometriosis with TPM imaging of the same excitation/emission pair. Hemosiderin is particularly relevant because is present in early-onset endometriosis [9] . Further, it is known that columnar epithelial cells, found in endometriosis glands, form fluid filled glandular structures and OCT is an optical technique capable of easily identifying fluid filled spaces in tissues [10] . Therefore, we hypothesized that OCT could be a second optical tool in the detection of endometriosis. We tested these hypotheses on ex vivo tissue samples collected by gynecologic surgeons from women suspected of having endometriosis. Samples were classified by the surgeon as yes or maybe for the presence of endometriosis, with suspected negative controls also excised, and these samples were then evaluated with both optical techniques and compared to the gold standard, histologic diagnosis. The histologic diagnosis was made by a gynecologic pathologist (PTV) blinded to the results of the OCT-TPM imaging.
Methods
The tissue samples were collected at two clinical sites, University of Texas Health Science Center at San Antonio, and Methodist Healthcare System in San Antonio. Participants were enrolled between December 18, 2014 and June 6, 2017 in a prospective manner. Two experienced gynecologic surgeons (RDR, BC), each with greater than 25 years' experience diagnosing and treating endometriosis performed all of the surgical procedures.
Ethical approval
IRB approval for this study was obtained at both clinical sites. Background information was collected on patients' age and race, medical history, and list of medications. Subjects were approached for consent if they were undergoing surgery for suspected endometriosis for clinical indications. Informed consent was obtained for all participants. Subjects were withdrawn if no suspected endometriosis was identified at the time of surgery. The mean participant age was 37 (range 22-46).
Sample collection
Peritoneal biopsy samples were collected at the time of laparoscopic surgery and the surgeons were asked to make a clinical diagnosis of each sample removed as "yes", "no", or "maybe" for endometriosis. The location of origin of these samples was also recorded. Clinically defined endometriosis was described as red, black, or white lesions. The samples designated in the "no" category were control samples of normal appearing peritoneal tissue biopsied by the surgeon. These three categories allowed us to develop optical signatures of endometriosis. The "maybe" category allowed us to determine if these optical properties could improve the sensitivity and specificity of the surgeon's clinical diagnosis. The "maybe" samples represent suspected disease that some surgeons might remove and others might not depending on location and appearance.
Once the samples were received, imaging was performed to categorize optical properties. Samples were embedded in agar using a 4x4x2 mm mold and imaged in the mold. The mold allowed for co-registration with histology. Specifically, pre-embedding in a mold allowed the preservation of tissue orientation and location throughout imaging and histological processing. Knowledge of tissue orientation allows exact 3D co-registration between the OCT-TPM images and stained histologic slides.
Imaging procedures
Optical imaging was performed with three imaging systems, Optical Coherence Tomography (OCT), Two-Photon Microscopy (TPM), and Wide-Field/Single-Photon Fluorescence. Imaging was performed within 24 h of sample excision. OCT imaging was performed on a benchtop OCT system built in our lab, using Alazar (Pointe-Claire, QC, Canada) and Santec (Hackensack, NJ, USA) sources, which operate between 1250 and 1376 nm. These systems recorded b-scans for the entire sample volume (up to 6.25 × 6.25 × 2 mm). Lateral resolution was 6.1-12.21 μm/ pixel. Axial resolution was 3.75-8 μm/pixel. The targets for OCT imaging were glands. The presence of endometriosis detected by OCT was a void in the image which corresponded to a fluid-filled gland in the histology. OCT penetration depth and wide-field also provided a full volume view of the samples, ranging in size from 12 to 27 mm 3 , useful for later co-registration with histology. The second optical target for endometriosis was the intrinsic fluorescence of hemosiderin. Hemosiderin has an excitation peak of 450 nm, and an emission peak near 680-690 nm. TPM imaging and Single Photon fluorescence imaging were performed on a Prairie View microscope system (Middleton, WI, USA). TPM was performed using an excitation wavelength of 900 nm (twice the one-photon excitation peak). Fluorescence images using emission channels, 500 nm, 560 nm, 620 nm, and 690 nm, were recorded. Hemosiderin was identified by increased pixel intensity in the 690 nm emission channel. TPM images were taken with a field of view of 735 μm. Z-series with 10 μm step-size were taken and stitched together to image the entire sample. Z-series (stacks of images) were taken in depth until the image was no longer interpretable (approximately 200 μm). TPM had a resolution of 1.44 μm/ pixel. Additionally, single-photon wide-field fluorescence images were recorded using an excitation source emitting at 420 + − 20 nm and an emission filter of 690 + − 20 nm to demonstrate hemosiderin detection with standard fluorescence imaging as seen in increased pixel intensity. This method is less expensive than TPM and therefore more translatable to a clinical device.
Histologic processing
The slides underwent histologic processing. Slides were taken every 40 μm for the first 400 μm and every 100 μm subsequently. Paraffin slides were stained with Hematoxylin and Eosin. For the histologic evaluation, each sample was categorized for the presence of the three histologic markers for endometriosis: glands (columnar endothelial cells), stroma, and hemosiderin. The histologic diagnosis was used as the gold standard against which the surgeons' and imaging systems' findings were compared. Due to the exactness of the match from the use of agar, the optical properties of specific markers were obtained. Unique features in the images were identified as matching the histologic markers.
Statistical analyses
Sensitivity, specificity and negative and positive predictive values for the accuracy of both the imaging systems and the surgeons' impressions were calculated. Sensitivity was calculated by taking the number of true positives (histologically confirmed endometriosis) and dividing by the sum of the number of true positives and false negatives (histologically confirmed endometriosis that was not detected by the surgeon or imaging systems). Specificity was calculated by taking the number of true negatives (histology confirmed to lack endometriosis) and dividing by the sum of the number of true negatives and false positives (histology confirmed to lack endometriosis but identified as disease positive by the surgeon or imaging system). Positive predictive value was calculated by taking the number of true positives and dividing by the sum of true positives and false positives. Negative predictive value was calculated by taking the number of true negatives and dividing by the sum of true negatives and false negatives.
Results
OCT was used to identify fluid filled glands and two-photon microscopy (TPM) to detect the endogenous fluorescence of tissue without exogenous labels, specifically hemosiderin. Results show that glands are visible via OCT imaging (Fig. 1a) and hemosiderin has endogenous fluorescence that is present both in multi-photon (Fig. 1b) and single-photon fluorescence imaging (Fig. 1c) .
Clinical impression
This study enrolled 41 women. Based on the clinical diagnosis of the physician, 27 women had endometriosis and 14 did not. These 14 women were determined to have no endometriosis lesions by the surgeon and no biopsies were obtained for ethical reasons. The results outlined below focus on the remaining 27 subjects. Of these 27 subjects, 18 had advanced optical imaging performed with OCT and TPM.
Histology
For the set of 27 subjects the surgeon's diagnosis of 120 biopsies was compared to the histologic gold standard. The surgeon diagnosed 65 of these as definite endometriosis, 31 as maybe for endometriosis, andHemosiderin was a prevalent marker seen in 49 of 57 (86%) endometriosis samples proven positive by histology. Glands were found in pathology in 28 of the 57 (49%) of endometriosis positive samples. The final marker, stroma, was found in 41 of the 57 samples (72%), although not an optical target for advanced imaging.
Advanced optical imaging
It was possible to obtain full optical imaging sets for 18 of the 27 patients outlined above. This resulted in 113 optical imaging sets of co-registered OCT, TPM and histology from 86 biopsy samples. Results are shown in Tables 1, 2, and 3. TPM confirmed the presence of hemosiderin with a visible endogenous fluorescence signal in all 36 of those samples where it was confirmed by histology and did not have a single false positive in the other 50 samples (Fig. 2 ). Glands were visible in OCT for 17 of the 21 samples for which they were seen in histology. OCT for glands lacks a PPV and specificity due to lack of a true false positive. This is due to OCT's optical marker for glands being able to be co-registered with its histologic counterpart, but it is difficult to examine the OCT image and read a false positive that corresponds to histology.
Single photon results
To allow for clinical translation of hemosiderin as an optical target, 4 subjects were further examined by an additional imaging technique, single-photon fluorescence. Fig. 1 Imaging Results. 1a Sample 29-1a, the top image is the OCT en face image, the bottom image is the histology, the identified gland is boxed in red, scale bar is 1 mm 1b Sample 20-6, TPM image on top, histology on bottom, hemosiderin is circled in red and appears as brown in the histology due to H&E stain, the TPM image is colored based on emission channel, the red represents 690 nm (hemosideran), blue is 500 nm (collagen), scale bar is 1 mm 1c: Sample 34-1 The image on the top left is the single photon microscopy/ wide field fluorescence, very bright spots match with TPM and histology as hemosiderin, the image on the top right is the corresponding TPM image location colored as stated in 1b these are scale to 470 um × 470 um, the bottom right is the full TPM image and bottom left is the corresponding histology, the red box represents the area of the top images, scale bar is 1 mm PPV is positive predictive value, NPV is negative predictive value, SENS is sensitivity, SPEC is specificity Surgical Impression is based on the surgical diagnosis of all samples taken from 27 subjects against histological diagnosis. OCT-TPM combined is the optical markers from both imaging type predication of endometriosis against histological diagnosis. OCT-TPM was only available in 18 of 27 patients with endometriosis. One hundred thirteen optical imaging sets were available from these 18 patients for OCT-TPM. OCT for glands lacks a PPV and specificity due to lack of a true false positive. TPM for hemosiderin and OCT for glands is specifically the identification of the marker in the imaging data against histologic confirmation of the marker
This evaluation examined 6 biopsies from these 4 patients identified by TPM to be hemosiderin positive, and 2 controls shown by TPM to be hemosiderin negative. Single-photon was able to detect hemosiderin similar to TPM, in the exact areas and identical pattern as TPM, and was confirmed by histology (Fig. 1c) .
Discussion
Our results demonstrate the benefit of adding advanced optical imaging in the diagnosis of endometriosis. The clinician made a correct clinical diagnosis in 67% of histologic positive samples. Endometrial glands are helpful if present but were only found in histology in 28 of the 57 endometriosis positive samples or 49% of the time. Glands were visible in OCT for 19 of the 23 imaging sets for which they were seen in histology. The significant finding was the frequency that hemosiderin was present. Hemosiderin was found in 86% percent of all histologic samples, and correctly identified with TPM 100% of the time; as well as, in single photon fluorescence imaging, which will allow clinical translation of hemosiderin identification to the operating room.
Specifically, these data demonstrate the need for a better detection method than a surgeon's clinical diagnosis. Of the 65 samples of endometriosis removed where the gynecologic surgeon was certain that endometriosis was present, the surgeon was incorrect 21 times, confirming prior reports of the relatively poor visual diagnosis of endometriosis lesions during laparoscopic surgery for endometriosis. We had two experienced gynecologic surgeons at two institutions and generated 120 total tissue samples for evaluation. Our data is comparable with results from studies with larger cohorts, Mettler reported a 53.8% positive rate in biopsies of suspected endometriosis [11] and Stratton a 61% rate [12] . Stegmann reported in her 133 patient, 611 sample study, a true positive rate of 65.0% rate which is very similar to our 67% rate but she found a much higher false negative rate of 12% compared to our 4% [4] .
There are several implications of our results regarding surgeons removing too much tissue in 1/3 of cases and missing lesions that should be removed. If any endometriosis is being missed and left in the patient, the chances for improving patient outcomes of pain reduction and possibly increased fertility, and preventing the high persistence rates common in endometriosis, are diminished. The low specificity and PPV reveals how much non-endometriosis tissue the surgeons are removing during the procedure and how much unproductive surgical time is added to the procedure. The one false negative result reveals that there is diseased tissue that is being left behind because the physician could not determine that a negative biopsy was actually endometriosis. This study also examined "maybe" samples, where the surgical diagnosis was unclear. These samples proved to be positive for endometriosis 39% of the time. Our combined TPM-OCT imaging accurately classified every "maybe" case. This shows the additive value of an advanced optical imaging approach, which would assist the surgeon in accurately identifying endometriosis where it is unclear whether endometriosis is present or not.
TPM-OCT detection overcomes many of the limitations of other methods developed to improve detection. Studies have shown that specific endometriosis lesions 
are not easily identified laparoscopically or by CT, MRI or ultrasound, unless there are large masses [13, 14] . This limits the surgical relevance of these technologies. Limited success in detecting endometriosis has been seen in comparing blue light adsorption of surrounding tissue with endometriosis, which does not absorb blue light. However blue light techniques do not provide a mechanistic link with a histological gold standard, such as stroma, glands, or hemosiderin and thus its value to clinicians has been questioned and not adopted [15] . Other imaging methods use exogenous materials such as the photo-sensitizer 5-ALA, Firefly™ fluorescence imaging (ICG), and blue dye [15, 16] . All have had limited success in identifying markers associated with endometriosis, including angiogenesis and enhanced vascularity, changes in the peritoneal tissue surrounding endometriosis, and continued epithelial bleeding. However, the indirect nature of these approaches has also limited widespread adoption. Thus, newer techniques are needed that are both diagnostic based on the true histologic pathology of endometriosis, and marker free as will be shown in a more detailed discussion of these competing optical techniques below. Demco and co-workers published [17] an endometriosis blue light reflectance/absorption imaging method. The authors hypothesized that lesions not visible under white light were visible under blue light reflectance because porphyrin molecules in endometriosis absorb blue light. This is not an auto fluorescence technique as it looks at absorption of blue light and not emission from excitation. Our TPM detection of hemosiderin looks at the emission signal from excited hemosiderin. Demco's method has not been rigorously tested since there are no sensitivity and specificity results published [17] . Furthermore, the spectral analysis of Demco's technique will not reveal endometriosis below the surface such as unrecognized intra-ovarian endometriosis, since it relies on surface reflection. Our technique depends on endogenous fluorescence emission and will identify lesions below the surface since we are detecting emitted photons which can pass through layers of tissue. Buchweitz et al. developed an auto-fluorescence technique to detect differences between normal tissue and endometriosis [18] . They hypothesized that well known auto-fluorescence of NADH, and ATP has a different fluorescence pattern in endometriosis tissue compared to normal tissue. The reasoning behind their approach is that endometriosis has a different metabolic activity than surrounding tissues, and different metabolic rates can be revealed in auto-fluorescence imaging due to the different endogenous fluorescence's of NAD+ and NADH, and ATP and ADP. With Buchweitz's method endometriosis was identified by decreased fluorescence compared to surrounding tissue, looking for a reduction in auto-fluorescence as the marker for endometriosis. The emission wavelengths of those molecules are shorter than the emission wavelength of the porphyrin in hemosiderin, which might explain why they did not see the enhanced fluorescence from hemosiderin as we did [7, 8] . Looking for a reduction in fluorescence is flawed in that this approach detects a negative image or the absence of a signal.
Another approach utilizes exogenous fluorescence with application of δ-Aminolevulinic acid (5-ALA) which was originally developed for photodynamic therapy in cancer. It has been applied for the detection and treatment of endometriosis. 5-ALA follows the heme pathway and goes into proto-porphyrin IX. They thus are using a similar marker with a similar excitation/ emission as our TPM detection of hemosiderin. However, 5-ALA has several drawbacks. First as an exogenous material it requires a 24-h hospital stay due to its nature as a photo-sensitizer [19] . 5-ALA is a precursor of protoporphyrin IX (PPIX) in the heme pathway. However, PPIX is not in hemosiderin [20] , thus 5-ALA targets the increased degree of angiogenesis and vascular endothelial growth factor expression consistent with endometriosis. Our techniques present better diagnostic options because they are label free and target physical components of endometriosis rather than metabolic pathways expressed by endometriosis. Another competing technology is Firefly™ fluorescence imaging which uses indocyanine green (ICG) as an exogenous marker which identifies blood vessels. It has been used in endometriosis detection as it can identify neovascularization associated with endometriosis [21] . Beyond being an exogenous marker, it has several other shortcomings in detection. Specifically, as not all endometriosis presents as 'red' vascularized endometriosis, its ability to accurately detect black and white endometriosis is poor and other methods that do not rely on angiogenesis are needed [22] .
A criticism of using TPM to identify hemosiderin is the high cost of the two photon instrument to be used in the operating room. As a result, we evaluated whether the low cost option of single photon fluorescence could be implemented to also identify hemosiderin in endometriosis and found similar accuracy. Clinical translation of these results to a cost-effective device has been built, programed, and its camera and electronic components have been tested. We are currently repeating our studies using this single photon device which can easily be inserted into a laparoscope for clinical translation at low cost. The clinical application of a laparoscope using the specific fluoroscopy detailed in this paper could provide surgeons with the ability to more accurately detect and removed endometriosis.
There are some limitations to our study. Glands and hemosiderin are not present in every endometriosis lesion. Even a TPM imaging system would miss some lesions due to their lack of hemosiderin. However it does present an improved option compared to white light, as TPM has better statistical accuracy. Only 18 of 27 patients identified by the surgeon as having endometriosis had OCT and TPM imaging performed. The clinical study was started before we fully solved the difficult technical issue of co-registration of histology and the region of tissue optically imaged. Embedding the tissue in a cube of agar allowed us to maintain tissue orientation and thus co-registration. Finally, our studies only enrolled a limited number of subjects. Our findings will be expanded on a larger number of patients focusing on single photon in the future. A prospective randomized trial in vivo will have to be completed to ultimately prove the relevance of our findings.
Conclusions
In summary, focusing on hemosiderin with single photon fluorescence should yield a surgical device capable of improving the detection of endometriosis and allowing clinical translation in a cost effective approach. Both glands seen by OCT and hemosiderin seen by TPM improve a surgeon's ability to correctly diagnose endometriosis. This is demonstrated in improved negative and positive predictive values as compared to the clinical impression of the surgeon. The improved diagnosis by OCT-TPM may result in fewer false positive results and increased disease tissue removed, although this will have to be tested in a prospective clinical trial. 
